1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells
Authors:
- Donald M. McCarthyDMDonald M. McCarthy
- Jesus F. San MiguelJMJesus F. San Miguel
- Hedley C. FreakeHFHedley C. Freake
- Philip M. GreenPGPhilip M. Green
- Heddy ZolaHZHeddy Zola
- Daniel CatovskyDCDaniel Catovsky
- John M. GoldmanJGJohn M. Goldman
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 7 (1) , 51-55
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- 1α,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60)Biochemical Journal, 1982
- The Preparation and Properties of Monoclonal Antibodies against Human Granulocyte Membrane AntigensBritish Journal of Haematology, 1981
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981
- A monoclonal antibody reactive with human peripheral blood monocytes.The Journal of Immunology, 1980
- Osteoclasts derived from haematopoietic stem cellsNature, 1980
- Direct Resorption of Bone by Human MonocytesScience, 1977
- Bone Resorption Restored in Osteopetrotic Mice by Transplants of Normal Bone Marrow and Spleen CellsScience, 1975
- 1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue CultureScience, 1972
- Cytochemical Identification of Monocytes and GranulocytesAmerican Journal of Clinical Pathology, 1971
- Origin of osteoclasts from mononuclear leucocytes in regenerating newt limbsThe Anatomical Record, 1962